Overview

Dr. Christopher Davis serves as Executive Director Research Operations at AdventHealth, with responsibilities for the Oncology, Translational Research Institute for Metabolism and Diabetes, Cardiovascular, Neuroscience, Digestive Health Surgical Institute, and Pediatric Research teams. Prior to his current appointment, Dr. Davis served as Director for the Translational Research Institute for Metabolism and Diabetes, where he facilitated administrative and operational processes to support the clinical research goals of the department. 

Dr. Davis earned his Ph.D. from the Department of Biochemistry and Molecular Biology in the College of Medicine at the University of Florida, Gainesville. He then undertook his postdoctoral training in the laboratory of Dr. Eric Olson at the University of Texas Southwestern Medical Center, Dallas where his primary research focus was to better understand the molecular mechanisms of cardiovascular development and disease.   

Following his postdoctoral training, Dr. Davis joined the Cardiovascular and Metabolic Disease Department at Wyeth Pharmaceuticals where he led efforts to identify and validate novel therapeutic targets for heart failure. Following his tenure at Wyeth, he joined the Hypertension Department within Merck Research Laboratories where he focused on developing, validating, and leveraging pre-clinical models of cardiovascular and cardiopulmonary disease.